ACN Newswire

Tue Feb 2

Eisai to Launch Parkinson's Disease Treatment Equfina in South Korea

Written by ACN Newswire

TOKYO, Feb 1, 2021 - (JCN Newswire) - Eisai Co., Ltd. announced today that Eisai Korea Inc., Eisai's subsidiary in South Korea, has launched the Parkinson's disease treatment Equfina (safinamide mesilate, "safinamide"). This is the first launch of Equfina in the Asian region excluding Japan.The estimated number of patients with Parkinson's...

ACN Newswire

Eisai to Launch Parkinson's Disease Treatment Equfina in South Korea

Here's how to support quality teaching, with the evidence to back it

The government's $2bn climate fund: a rebadged rehash of old mistakes

Why Everyone Needs Business Insurance This Year

Local newspapers are an 'essential service'. They deserve a government rescue package, too

Obesity is a market failure and innovation, not sin taxes, may be the solution

Poker - an old game with new technologies

Media raids raise questions about AFP's power and weak protection for journalists and whistleblowers

Telling the forgotten stories of Indigenous servicemen in the first world war

Nearly 30% of kids experience sibling bullying – as either bully or victim

The Liberal Party is failing women miserably compared to other democracies, and needs quotas

Coronavirus is stressful. Here are some ways to cope with the anxiety